Enbrel slows the destruction of joints by disrupting TNF activity. Which pharmacologic class does it belong to?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Study for the Pharmacology Drug Classifications Test with multiple choice questions and comprehensive explanations. Enhance your knowledge effectively and ace your exam!

Multiple Choice

Enbrel slows the destruction of joints by disrupting TNF activity. Which pharmacologic class does it belong to?

Explanation:
Blocking tumor necrosis factor defines this drug’s pharmacologic class. Enbrel (etanercept) acts as a decoy receptor that binds TNF-α, preventing it from activating its receptors and driving the inflammatory cascade that damages joints. That specific mechanism makes it an antitumor necrosis factor agent. It’s more precise than the broad “anti-inflammatory,” and it isn’t categorized as an antineoplastic or antituberculosis drug.

Blocking tumor necrosis factor defines this drug’s pharmacologic class. Enbrel (etanercept) acts as a decoy receptor that binds TNF-α, preventing it from activating its receptors and driving the inflammatory cascade that damages joints. That specific mechanism makes it an antitumor necrosis factor agent. It’s more precise than the broad “anti-inflammatory,” and it isn’t categorized as an antineoplastic or antituberculosis drug.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy